Fundeni Clinical Institute "Stefan Berceanu" Center for Hematology and Bone Marrow Transplant

Bucharest 022328

0 studies enrolling now · 2 studies all time

What they study most

Acute Myeloid Leukemia (AML), Secondary Acute Myeloid Leukemia (Secondary AML, sAML)

Studies at this site

• Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML) — Completed
• Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study — Status unconfirmed